Down syndrome with and without dementia: An in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease (original ) (raw )\u3csup\u3e1\u3c/sup\u3eH-MRS Metabolites in Adults with Down Syndrome: Effects of Dementia
Gregory Jicha
2016
View PDFchevron_right
1H-MRS metabolites in adults with Down syndrome: Effects of dementia
Gregory Jicha
NeuroImage: Clinical, 2016
View PDFchevron_right
Serum MHPG strongly predicts conversion to Alzheimer's disease in behaviorally characterized subjects with Down syndrome
Yannick Vermeiren
Journal of Alzheimer's disease : JAD, 2015
View PDFchevron_right
The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy
Akihiko Shiino
Journal of Cerebral Blood Flow & Metabolism, 2012
View PDFchevron_right
Regional Gray and White Matter Metabolite Differences in Subjects With AD, With Subcortical Ischemic Vascular Dementia, and Elderly Controls With 1H Magnetic Resonance Spectroscopic Imaging
George Fein
Archives of Neurology, 1996
View PDFchevron_right
The heritability of brain metabolites on proton magnetic resonance spectroscopy in older individuals
Perminder Sachdev
NeuroImage, 2012
View PDFchevron_right
Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome
Bradley Christian
Journal of Alzheimer's disease : JAD, 2018
View PDFchevron_right
Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
Melina Uncapher
Neurology, 2003
View PDFchevron_right
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome
Elizabeth Head
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
View PDFchevron_right
Down syndrome, increased risk of dementia and lipid disturbances
Maciej Jankowski
Journal of mother and child, 2021
View PDFchevron_right
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer disease brains
jorge bahena
2021
View PDFchevron_right
The “develOpment of metabolic and functional markers of Dementia IN Older people” (ODINO) Study: Rationale, Design and Methods
Jacopo Gervasoni
Journal of Personalized Medicine, 2020
View PDFchevron_right
Metabolic signatures of human Alzheimer’s disease (AD): 1H NMR analysis of the polar metabolome of post-mortem brain tissue
Stewart Graham
Metabolomics, 2013
View PDFchevron_right
Exploring Changes in Primary Metabolites in Alzheimer ’ s Disease using Targeted LC-MS / MS MSACL 2016 EU
Nicola Gray
2016
View PDFchevron_right
Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults
Hamid R Sohrabi
Journal of Neurochemistry, 2020
View PDFchevron_right
Age-Related Changes in Plasma Dehydroepiandrosterone Levels in Adults with Down’s Syndrome and the Risk of Dementia
Joe Herbert
Journal of Neuroendocrinology, 2011
View PDFchevron_right
Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis
Jingyun Yang
Neurobiology of Aging, 2019
View PDFchevron_right
Hippocampal Volumes, Proton Magnetic Resonance Spectroscopy Metabolites, and Cerebrovascular Disease in Mild Cognitive Impairment Subtypes
Maria Shiung
Archives of Neurology, 2008
View PDFchevron_right
Magnetic Resonance Spectroscopy in Alzheimer’s Disease: Systematic Review and Meta-Analysis
Wen-Ying Wang
Journal of Alzheimer's Disease, 2015
View PDFchevron_right
Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis
Frederick Schmitt
Frontiers in aging neuroscience, 2018
View PDFchevron_right
Effects of Alzheimer Disease on Fronto-parietal Brain N-acetyl Aspartate and Myo-Inositol Using Magnetic Resonance Spectroscopic Imaging
Frank Ezekiel , Brian Soher
Alzheimer Disease & Associated Disorders, 2006
View PDFchevron_right
Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition: a validation study
Shona Pedersen
Metabolomics, 2024
View PDFchevron_right
Recent advances in the application of metabolomics to Alzheimer's Disease
Eugenia Trushina
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
View PDFchevron_right
Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: A 1H-MRS study
Yves De Deene
European Journal of Radiology, 2012
View PDFchevron_right
A Longitudinal Study of Dementia of Alzheimer Type in Down's Syndrome
Arne Brun
Dementia and Geriatric Cognitive Disorders, 1991
View PDFchevron_right
Discrepancy between Alzheimer-Type Neuropathology and Dementia in Persons with Down's Syndrome
Ausma Rabe
Annals of The New York Academy of Sciences, 1986
View PDFchevron_right
Plasma metabolome and cognitive skills in Down syndrome
Chiara Locatelli
Scientific Reports
View PDFchevron_right